| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $852.5M | +115.1% |
| Cost of Revenue | $207.3M | +121.5% |
| Gross Profit | $645.3M | +113.2% |
| R&D Expense | $304.0M | +51.4% |
| SG&A Expense | $88.1M | -6.6% |
| Operating Income | $173.4M | +249.4% |
| Pre-tax Income | $218.2M | +366.8% |
| Income Tax | -$981K | -159.7% |
| Net Income | $219.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167.6M | +110.7% |
| Accounts Receivable | $83.2M | +114.4% |
| Inventory | $59.0M | +36.5% |
| Current Assets | $1.36B | +34.5% |
| Total Assets | $1.53B | +45.3% |
| Current Liabilities | $133.0M | +53.7% |
| Total Liabilities | $168.2M | +87.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $319.3M | +133.6% |
| Capital Expenditures | $37.5M | +9.6% |
| Investing Cash Flow | -$241.5M | +68.1% |
| Financing Cash Flow | $9.8M | -98.5% |
| Free Cash Flow | $281.8M | +175.1% |
| +362.7% |
| EPS (Basic) | $1.32 | +306.3% |
| EPS (Diluted) | $1.22 | +290.6% |
| Stockholders' Equity |
| $1.36B |
| +41.3% |